Skip to main content
ABVXAbivax SASell5.9·$92.52
ABVX · Decision

Should you buy Abivax (ABVX)?

Updated

Abivax is growing revenue at 35% year-over-year with analyst consensus implying 52% upside to the price target, but cash burn running at -2,327% of revenue and a quality profile below the minimum quality threshold make this a high-risk, speculative situation where the growth must eventually translate into cash economics.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Verdict
SELL
Score
5.9/10
Price
$92.52
Entry / Take Profit (TP) / Stop Loss (SL)
/ $131.13 / $86.03

Engine methodology range

Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.

What the engine is tracking

With free cash flow at -2,327% of revenue, a negative operating margin of -1.7%, and debt-to-equity of 4.1, the company exhibits the defining characteristics of a value trap: headline revenue growth alongside severe capital consumption that may not be sustainable.

Stable
Warnings
Expectation
This pillar is invalidated if the cash burn rate improves to less than 500% of revenue and operating margins turn positive for 2 consecutive quarters.

CounterA recent analyst coverage event produced a positive sentiment signal, and the 35% revenue growth rate may represent early-stage scale-up dynamics where negative cash flow is expected before a key catalyst converts the economics.

Revenue has grown 35% year-over-year, a rate that, if sustained, would provide the top-line momentum needed to eventually close the cash burn gap and improve unit economics as the business scales.

Stable
Growth breakdown
Expectation
Revenue growth stays above 20% year-over-year for the next two reported periods, demonstrating the growth trajectory is not decelerating.

CounterCash is burning at -2,327% of revenue and the Rule of 40 score is deeply negative at -2,291, suggesting that growth is being purchased at an unsustainable cost; capital may run short before the growth compounds to profitability.

Analysts have set a consensus price target implying 52% upside to $129.71 from the current price of $98.26, and a recent analyst event contributed a positive sentiment signal of +0.60; if the growth narrative holds, this coverage could attract a broader investor base.

Stable
Sentiment breakdown
Expectation
Analyst consensus price target holds above $120.00 over the next 6 months; additional analyst initiations appear.

CounterThe average EPS surprise across the last four quarters is -52%, indicating analysts have consistently overestimated performance; large price targets in deeply cash-negative names often carry limited predictive value and can compress rapidly on negative news.

▸ Show 1 more pillar

Although the stock trades below its 200-day moving average, that average is still rising at +7.4% per month and on-balance volume is accumulating — suggesting the recent price weakness may be a pullback within an intact uptrend rather than a structural breakdown.

Stable
Momentum breakdown
Expectation
Price recovers above the 200-day moving average within 2 months while the moving average slope remains positive.

CounterMomentum has failed its required minimum threshold, MACD is negative, and implied volatility of 146% indicates the market is pricing extreme uncertainty; the uptrend read may prove premature if capital needs force a dilutive capital raise.

→ Full pillar scorecard with all 4 pillars + per-dimension breakdown

When this thesis breaks

Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Revenue has grown 35% year-over-year, a rate that, if sustained, would provide the top-line momentum needed to eventually close the cash burn gap and improve unit economics as the business scales.

    Trip ifRevenue growth falls below 20% YoY for 2 consecutive quarters.

  • P2With free cash flow at -2,327% of revenue, a negative operating margin of -1.7%, and debt-to-equity of 4.1, the company exhibits the defining characteristics of a value trap: headline revenue growth alongside severe capital consumption that may not be sustainable.

    Trip ifOperating cash burn rate improves to less than 500% of revenue for 2 consecutive quarters.

  • P3Analysts have set a consensus price target implying 52% upside to $129.71 from the current price of $98.26, and a recent analyst event contributed a positive sentiment signal of +0.60; if the growth narrative holds, this coverage could attract a broader investor base.

    Trip ifAnalyst consensus price target falls below $110.00, reducing implied upside to less than 12% from current levels.

  • P4Although the stock trades below its 200-day moving average, that average is still rising at +7.4% per month and on-balance volume is accumulating — suggesting the recent price weakness may be a pullback within an intact uptrend rather than a structural breakdown.

    Trip if200-day moving average slope falls below 0% for 4 consecutive weeks.

How the engine reached this verdict

1. Direct answer

TrendMatrix's engine output for Abivax SA (ABVX) is SELL_IF_HOLDING with medium conviction, score 5.9/10 at $92.52. An L1 hard-floor gate blocked the positive-verdict path — Quality below minimum threshold. Co-failing gates ( MOMENTUM:3.5<4.5) reinforce the read; dimensional pillars cannot lift the engine output above the verdict floor while the L1 gate is active.

2. What would change the verdict

The dominant failed gate is momentum at 3.5 vs threshold 4.5. SELL flips back toward HOLD if momentum recovers above its threshold AND a co-failing gate also clears. The strongest-cleared gate today is ASYMMETRY:2.8>=1.5.

3. What the engine sees

On the bear side: Quality below floor (3.5 < 4.0); Value-trap signals (2/5): Margin compression (op margin -1.7%), High leverage (D/E 4.1). Active engine warnings: Quality below floor (3.5 < 4.0), Value-trap signals (2/5): Margin compression (op margin -1.7%), High leverage (D/E 4.1), V9 Gate Failed: MOMENTUM:3.5<4.5.

4. Entry, target, and stop

The engine's exit framework anchors to a tactical sell band near $92.52, with structural invalidation at $86.03. The asymmetric R:R against a reversal hypothesis is 5.96 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).

For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates ABVX — 10-dimension breakdown →

Bear case

  • Quality below floor (3.5 < 4.0)
  • Value-trap signals (2/5): Margin compression (op margin -1.7%), High leverage (D/E 4.1)
Home Stocks ABVX Buy or sell?